Synageva Seeks $78M to Advance Orphan Drugs Pipe
By Marie Powers
Friday, January 6, 2012
Synageva BioPharma Corp. priced its underwritten public offering of common stock, seeking to raise $78.3 million by selling 3,108,057 shares at $25.18 per share.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.